Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Rosuvastatin for CV Risk in Psoriatic Disease
NCT04417114Phase 4Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2021
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of rosuvastatin in cardiovascular disease (CVD), sponsored by Brigham and Women's Hospital. Planned start Apr 2021; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT04417114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417114.